Rebecca G Chackalackal, MD | |
University Of Iowa Student Health Service, 4189 Wl, Iowa City, IA 52242-1100 | |
(319) 335-8370 | |
(319) 335-7247 |
Full Name | Rebecca G Chackalackal |
---|---|
Gender | Female |
Speciality | Family Medicine |
Location | University Of Iowa Student Health Service, Iowa City, Iowa |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1609863323 | NPI | - | NPPES |
1192815 | Medicaid | IA | |
55711 | Other | IA | WELLMARK BCBS |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207Q00000X | Family Medicine | 33635 (Iowa) | Primary |
Entity Name | State University Of Iowa |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1477554814 PECOS PAC ID: 7618884230 Enrollment ID: O20031107000060 |
News Archive
Jackson T. Wright Jr., MD, PhD, and researchers from University Hospitals Case Medical Center presented new results from the Systolic Blood Pressure Intervention Trial (SPRINT) showing that in patients at high risk for cardiovascular events, targeting a systolic blood pressure of less than 120 mm Hg resulted in lower rates of fatal and non-fatal major events or death compared to targeting systolic blood pressure to the usually recommended target of less than 140 mm Hg.
Better care and more research into treatments for people experiencing a first manic episode are urgently needed, according to researchers at the NIHR Maudsley Biomedical Research Centre.
In the months after separating from military service, most veterans are less satisfied with their health than with their work or social relationships, found a study by Veterans Affairs researchers.
Ironshore Pharmaceuticals & Development, Inc. has signed an agreement with Restore Health, a company specializing in personalized medicine, to participate in the fulfillment of a double-blind clinical trial, designed to evaluate the safety and efficacy of HLD-200, a new drug in development to treat Attention-deficit/hyperactivity disorder (ADHD).
In most states, insurers charge older people much higher health insurance premiums than their younger counterparts, a practice companies say is "an unavoidable business decision" because the risk of getting sick rises with age, the Associated Press reports.
› Verified 7 days ago
Mailing Address | Practice Location Address |
---|---|
Rebecca G Chackalackal, MD University Of Iowa Student Health Service, 4189 Wl, Iowa City, IA 52242-1100 Ph: (319) 335-8370 | Rebecca G Chackalackal, MD University Of Iowa Student Health Service, 4189 Wl, Iowa City, IA 52242-1100 Ph: (319) 335-8370 |
News Archive
Jackson T. Wright Jr., MD, PhD, and researchers from University Hospitals Case Medical Center presented new results from the Systolic Blood Pressure Intervention Trial (SPRINT) showing that in patients at high risk for cardiovascular events, targeting a systolic blood pressure of less than 120 mm Hg resulted in lower rates of fatal and non-fatal major events or death compared to targeting systolic blood pressure to the usually recommended target of less than 140 mm Hg.
Better care and more research into treatments for people experiencing a first manic episode are urgently needed, according to researchers at the NIHR Maudsley Biomedical Research Centre.
In the months after separating from military service, most veterans are less satisfied with their health than with their work or social relationships, found a study by Veterans Affairs researchers.
Ironshore Pharmaceuticals & Development, Inc. has signed an agreement with Restore Health, a company specializing in personalized medicine, to participate in the fulfillment of a double-blind clinical trial, designed to evaluate the safety and efficacy of HLD-200, a new drug in development to treat Attention-deficit/hyperactivity disorder (ADHD).
In most states, insurers charge older people much higher health insurance premiums than their younger counterparts, a practice companies say is "an unavoidable business decision" because the risk of getting sick rises with age, the Associated Press reports.
› Verified 7 days ago
Joshua Craig Borwick, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 200 Hawkins Dr, Iowa City, IA 52242 Phone: 319-384-7507 | |
Kaylie Duit, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 200 Hawkins Dr, Iowa City, IA 52242 Phone: 319-384-7222 Fax: 319-384-7822 | |
Adelaide M Gurwell, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 200 Hawkins Dr, Iowa City, IA 52242 Phone: 319-356-1616 | |
Mr. Nathan Alan Shaw, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 200 Hawkins Dr, Iowa City, IA 52242 Phone: 319-384-7000 | |
Alexander Young-oo Dresden, DO Family Medicine Medicare: Medicare Enrolled Practice Location: 200 Hawkins Dr, Iowa City, IA 52242 Phone: 319-384-7222 Fax: 319-384-7822 | |
Dr. Maresi Berry-stoelzle, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 3640 Middlebury Rd, Iowa City, IA 52245 Phone: 319-384-7000 Fax: 319-467-7400 | |
Michael Maharry, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 200 Hawkins Dr, Iowa City, IA 52242 Phone: 319-384-7222 Fax: 319-384-7822 |